Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ashcroft

Showing results (681-690 of 759) with videos related to

Pageof 76
Sort By:
Plos One|March 28, 2025
Correction: Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections: Risk prediction models to tackle antimicrobial resistance in primary careAli Fahmi, Victoria Palin, Xiaomin Zhong, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
Biochemical Pharmacology|March 10, 2004
Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1Eun-Jee Park, Jae Hoon Bae, So-Yeon Kim, et al.
Plos Genetics|August 15, 2009
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO geneChris Church, Sheena Lee, Eleanor A L Bagg, et al.
Plos One|April 2, 2015
Pharmacological inhibition of FTOFiona McMurray, Marina Demetriades, WeiShen Aik, et al.
BJGP Open|July 10, 2023
UK research data resources based on primary care electronic health records: review and summary for potential usersLara Edwards, James Pickett, Darren M Ashcroft, et al.
Antimicrobial Resistance and Infection Control|September 16, 2023
The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in EnglandYa-Ting Yang, Xiaomin Zhong, Ali Fahmi, et al.
Diabetologia|February 25, 2005
A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J miceA A Toye, J D Lippiat, P Proks, et al.
Plos Medicine|November 16, 2022
Scaling-up a pharmacist-led information technology intervention (PINCER) to reduce hazardous prescribing in general practices: Multiple interrupted time series studySarah Rodgers, Amelia C Taylor, Stephen A Roberts, et al.
Frontiers in Public Health|July 3, 2025
Associations between burnout and career disengagement factors among general practitioners: a path analysisChristos Grigoroglou, Mark Hann, Alexander Hodkinson, et al.
Pageof 76

Showing results (681-690 of 759) with videos related to

Sort By:
Pageof 76
Plos One|March 28, 2025
Correction: Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections: Risk prediction models to tackle antimicrobial resistance in primary careAli Fahmi, Victoria Palin, Xiaomin Zhong, et al.
The British Journal of Dermatology|August 3, 2018
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Z Z N Yiu, D M Ashcroft, I Evans, et al.
Biochemical Pharmacology|March 10, 2004
Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1Eun-Jee Park, Jae Hoon Bae, So-Yeon Kim, et al.
Plos Genetics|August 15, 2009
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO geneChris Church, Sheena Lee, Eleanor A L Bagg, et al.
Plos One|April 2, 2015
Pharmacological inhibition of FTOFiona McMurray, Marina Demetriades, WeiShen Aik, et al.
BJGP Open|July 10, 2023
UK research data resources based on primary care electronic health records: review and summary for potential usersLara Edwards, James Pickett, Darren M Ashcroft, et al.
Antimicrobial Resistance and Infection Control|September 16, 2023
The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in EnglandYa-Ting Yang, Xiaomin Zhong, Ali Fahmi, et al.
Diabetologia|February 25, 2005
A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J miceA A Toye, J D Lippiat, P Proks, et al.
Plos Medicine|November 16, 2022
Scaling-up a pharmacist-led information technology intervention (PINCER) to reduce hazardous prescribing in general practices: Multiple interrupted time series studySarah Rodgers, Amelia C Taylor, Stephen A Roberts, et al.
Frontiers in Public Health|July 3, 2025
Associations between burnout and career disengagement factors among general practitioners: a path analysisChristos Grigoroglou, Mark Hann, Alexander Hodkinson, et al.
Pageof 76